Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma-Reference-Cited by-同舟云学术

Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma

Published:2018-01 Issue:1 Volume:18 Page:44-51
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Chari Ajai,Arinsburg Suzanne^ORCID,Jagannath Sundar,Satta Toshihisa^ORCID,Treadwell Ivey^ORCID,Catamero Donna,Morgan Gillian,Feng Huaibao,Uhlar Clarissa,Khan Imran,Doshi Parul^ORCID,Usmani Saad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. Human CD38: a (r)evolutionary story of enzymes and receptors;Deaglio;Leuk Res,2001

2. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma;Lin;Am J Clin Pathol,2004

3. Daratumumab, bortezomib, and dexamethasone for multiple myeloma;Palumbo;N Engl J Med,2016

4. Daratumumab, lenalidomide, and dexamethasone for mulitple myeloma;Dimopoulos;N Engl J Med,2016

5. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors;De Weers;J Immunol,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference of Monoclonal Antibody Therapy in Transfusion: An Update;Hemato;2024-07-02

2. A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India;Indian Journal of Hematology and Blood Transfusion;2024-04-01

3. Pretransfusion Testing and Daratumumab: Assessing Interference Risks and Developing Solutions;Global Journal of Transfusion Medicine;2024-01

4. How “Dara” You!;Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy;2023

5. Daratumumab: A drug with transfusion dilemma;Global Journal of Transfusion Medicine;2023